A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
Clinical trial NCT01033123 · COMPLETED
Trial details
- NCT number
- NCT01033123
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-02-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.